Cargando…

A traditional Chinese medicine therapy for coronary heart disease after percutaneous coronary intervention: a meta-analysis of randomized, double-blind, placebo-controlled trials

Huoxue Huayu therapy (HXHY) has been widely used to treat cardiovascular diseases in traditional Chinese medicine (TCM) such as hypertension and coronary heart disease (CHD). The present study describes a meta-analysis of a series of prospective randomized, double-blind, placebo-controlled trials co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Ruixue, Xiao, Ya, Chen, Minghao, He, Jingyi, Huang, Mengtian, Hong, Xitao, Liu, Xin, Fu, Taoran, Zhang, Jingzhi, Chen, Liguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435456/ https://www.ncbi.nlm.nih.gov/pubmed/30143584 http://dx.doi.org/10.1042/BSR20180973

Ejemplares similares

A Randomized Double-Blind Placebo-Controlled Trial to Evaluate Prophylactic Effect of Traditional Chinese Medicine Supplementing Qi and Hemostasis Formula on Gastrointestinal Bleeding after Percutaneous Coronary Intervention in Patients at High Risks
por: Zhang, Chenhao, et al.
Publicado: (2018)

Traditional Chinese Medicine in Patients With Primary Sjogren's Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Chen, Huang-Hsi, et al.
Publicado: (2021)

Serum Calprotectin Levels and Outcome Following Percutaneous Coronary Intervention in Patients with Diabetes and Acute Coronary Syndrome
por: Wang, Chengji, et al.
Publicado: (2019)

Traditional chinese medicine in coronary microvascular disease
por: Yang, Zhihua, et al.
Publicado: (2022)

Correlation Analysis between Traditional Chinese Medicine Syndromes and Gastrointestinal Bleeding after Percutaneous Coronary Intervention
por: Zhang, Chenhao, et al.
Publicado: (2018)

Systematic Review of Chinese Herbal Medicines for Preventing in-Stent Coronary Restenosis after Percutaneous Coronary Intervention
por: Zheng, Guo-Hua, et al.
Publicado: (2012)

In Silico Syndrome Prediction for Coronary Artery Disease in Traditional Chinese Medicine
por: Lu, Peng, et al.
Publicado: (2012)

A Study Protocol for a Randomized, Double-Blind, Placebo-Controlled Clinical Study on the Effect of Qishen Yiqi Dripping Pills on Exercise Endurance and Quality of Life in Patients with Coronary Heart Disease after Percutaneous Coronary Intervention
por: Yu, Linghua, et al.
Publicado: (2021)

Efficacy and safety of traditional Chinese medicine treatment for idiopathic pulmonary fibrosis: An exploratory, randomized, double-blinded and placebo controlled trial
por: Li, Jiansheng, et al.
Publicado: (2022)

Traditional Chinese Herbal Patch for Short-Term Management of Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Wang, Xuezong, et al.
Publicado: (2012)

The Application of Traditional Chinese Medicine Injection on Patients with Acute Coronary Syndrome during the Perioperative Period of Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Shi, Zhaofeng, et al.
Publicado: (2020)

Therapeutic efficacy of traditional Chinese medicine, Shen-Mai San, in cancer patients undergoing chemotherapy or radiotherapy: study protocol for a randomized, double-blind, placebo-controlled trial
por: Lo, Lun-Chien, et al.
Publicado: (2012)

Effectiveness and safety of Chinese herbal medicine xuanbi antong granules for the treatment of borderline coronary lesions: study protocol for a randomised, double-blinded, placebo-controlled, multicentre clinical trial
por: Huang, Mingyan, et al.
Publicado: (2019)

In Silico Investigation of Traditional Chinese Medicine for Potential Lead Compounds as SPG7 Inhibitors against Coronary Artery Disease
por: Chen, Kuen-Bao, et al.
Publicado: (2016)

A Randomized, Double-Blind, and Placebo-Controlled Trial of Chinese Herbal Medicine in the Treatment of Childhood Constipation
por: Qiao, Lei, et al.
Publicado: (2021)

Placebo-Controlled Efficacy of Percutaneous Coronary Intervention for Focal and Diffuse Patterns of Stable Coronary Artery Disease
por: Rajkumar, Christopher A., et al.
Publicado: (2021)

Clinical Efficacy of Traditional Chinese Medicine, Suan Zao Ren Tang, for Sleep Disturbance during Methadone Maintenance: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Chan, Yuan-Yu, et al.
Publicado: (2015)

Gut microbiota: a potential target for traditional Chinese medicine intervention in coronary heart disease
por: Cheng, Tian-Yi, et al.
Publicado: (2021)

Is the folk medicine known as “The Secret” efficient in reducing bleeding after percutaneous coronary procedures?: a double-blinded, randomised trial
por: Ferry, Charlie, et al.
Publicado: (2022)

Role of depression in secondary prevention of Chinese coronary heart disease patients receiving percutaneous coronary intervention
por: Feng, Can, et al.
Publicado: (2017)

A Randomized Double Blind Placebo Controlled Trial Examining the Effects of Pentoxifylline on Contrast Induced Nephropathy Reduction after Percutaneous Coronary Intervention in High Risk Candidates
por: Barzi, Farnaz, et al.
Publicado: (2019)

Traditional Chinese Medicine Combined With Chemotherapy and Cetuximab or Bevacizumab for Metastatic Colorectal Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Liu, Ningning, et al.
Publicado: (2020)

Efficacy and Safety of Traditional Chinese Medicine for Diabetes: A Double-Blind, Randomised, Controlled Trial
por: Ji, Linong, et al.
Publicado: (2013)

The Prognostic Value of Hematologic Inflammatory Markers in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Fan, Wenjun, et al.
Publicado: (2022)

Hair growth effect of traditional Chinese medicine BeauTop on androgenetic alopecia patients: A randomized double-blind placebo-controlled clinical trial
por: Lee, Chien-Ying, et al.
Publicado: (2017)

Modelling of inquiry diagnosis for coronary heart disease in traditional Chinese medicine by using multi-label learning
por: Liu, Guo-Ping, et al.
Publicado: (2010)

Traditional Chinese Medicine for Coronary Heart Disease: Clinical Evidence and Possible Mechanisms
por: Zhang, Ke-Jian, et al.
Publicado: (2019)

Therapeutic potential of traditional Chinese medicine on heat stroke
por: Li, Lei, et al.
Publicado: (2023)

Gender-specific cardiovascular outcomes in patients undergoing percutaneous coronary intervention in Chinese populations
por: Long, Juan, et al.
Publicado: (2020)

A randomized, double-blind, placebo-controlled, multicenter clinical trial for efficacy and safety of traditional Chinese medicine combined with antibiotics in the treatment of bacterial pneumonia in children
por: Wei, Lina, et al.
Publicado: (2020)

ASF (a Compound of Traditional Chinese Medicine) in the treatment of patients with alcohol dependence: Study protocol of a randomized, double-blinded, placebo-controlled clinical trial
por: Liang, Xianting, et al.
Publicado: (2020)

Traditional Chinese medicine syndrome differentiation and treatment by stages of Parkinson’s disease: study protocol for a multicentre, randomized, double-blind, placebo-controlled clinical trial
por: Hu, Yuqing, et al.
Publicado: (2022)

Use of pethidine for percutaneous liver biopsy – a randomised, placebo-controlled, double blind study
por: Pan, Antony, et al.
Publicado: (2015)

Advanced Lung Cancer Inflammation Index for Predicting Prognostic Risk for Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Wang, Xinchen, et al.
Publicado: (2023)

Percutaneous Coronary Intervention in an Extremely Rare Case of Double Circumflex Coronary Arteries With Acute Myocardial Infarction
por: Sidhu, Navdeep S, et al.
Publicado: (2022)

Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): A longitudinal analysis of a randomized, double‐blind, placebo‐controlled trial
por: Leal, José, et al.
Publicado: (2022)

Traditional Chinese medicine for acute coronary syndrome: A meta-analysis of clinical manifestations and objective indicators
por: Liao, Jiangquan, et al.
Publicado: (2021)

The Efficacy and Safety of Chinese Medicine Fufang Zhenzhu Tiaozhi Capsule (FTZ) in the Treatment of Diabetic Coronary Heart Disease: Study Protocol for Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Wang, Lexun, et al.
Publicado: (2021)

Impact of nodular calcification in patients with acute coronary syndrome (ACS) treated with primary percutaneous coronary intervention (PCI)
por: Demuyakor, Abigail, et al.
Publicado: (2022)

Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study
por: Rosano, Giuseppe MC, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_u8l43o12tst13sks0fb82uekh2